CRNX Operating Cash Flow
-$422.52MTTM · USD
Period ending:
CRNX FY Operating Cash FlowUSD
$0.00-$377.92M
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
CRNX operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -377,922,000 | |
| -225,970,000 | |
| -166,307,000 | |
| -115,205,000 | |
| -88,588,000 | |
| -62,027,000 | |
| -46,381,000 | |
| -19,459,000 | |
| -9,479,000 | |
| -5,468,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All CRNX financial metrics · CRNX stock overview · How to interpret financial metrics
